Literature DB >> 8617203

Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling.

F Weis-Garcia1, J Massagué.   

Abstract

Transforming growth factor-beta (TGF-beta) signals through two transmembrane serine/threonine kinases, T beta R-I and T beta R-II. TGF-beta binds to T beta R-II, allowing this receptor to associate with and phosphorylate T beta R-I which then propagates the signal. T beta R-I is phosphorylated within its GS domain, a region immediately preceding the kinase domain. To further understand the function of T beta R-I in this complex, we analyzed T beta R-I-inactivating mutations identified in cell lines that are defective in TGF-beta signaling yet retain ligand binding ability. The three mutations identified here all fall in the kinase domain of T beta R-I. One mutation disrupts the kinase activity of T beta R-I, whereas the other two mutations prevent ligand-induced T beta R-I phosphorylation, and thus activation, by T beta R-II. Unexpectedly, a kinase-defective T beta R-I mutant can functionally complement an activation- defective T beta R-I mutant, by rescuing its T beta R-II- dependent phosphorylation. Together with evidence that the ligand-induced receptor complex contains two or more T beta R-I molecules, these results support a model in which the kinase domain of one T beta R-I molecule interacts with the GS domain of another, enabling its phosphorylation and activation by T beta R-II. This cooperative interaction between T beta R-I molecules appears essential for TGF-beta signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617203      PMCID: PMC449943     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor.

Authors:  F T Boyd; J Massagué
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

2.  Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors.

Authors:  R H Chen; H L Moses; E M Maruoka; R Derynck; M Kawabata
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

Review 3.  Cytokine signaling through nonreceptor protein tyrosine kinases.

Authors:  T Taniguchi
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

Review 4.  Receptors for transforming growth factor-beta.

Authors:  K Miyazono; P Ten Dijke; H Ichijo; C H Heldin
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

5.  Two dominant-acting selectable markers for gene transfer studies in mammalian cells.

Authors:  S C Hartman; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Crystal structure of the tyrosine kinase domain of the human insulin receptor.

Authors:  S R Hubbard; L Wei; L Ellis; W A Hendrickson
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

7.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

8.  GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.

Authors:  R Wieser; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

9.  Reconstitution and transphosphorylation of TGF-beta receptor complexes.

Authors:  F Ventura; J Doody; F Liu; J L Wrana; J Massagué
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.

Authors:  C H McGowan; P Russell
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  39 in total

1.  Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers.

Authors:  S J Newfeld; R G Wisotzkey; S Kumar
Journal:  Genetics       Date:  1999-06       Impact factor: 4.562

2.  Genetic analyses demonstrate that bone morphogenetic protein signaling is required for embryonic cerebellar development.

Authors:  Lihua Qin; Lara Wine-Lee; Kyung J Ahn; E Bryan Crenshaw
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

3.  BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells.

Authors:  Joon Hyeok Kwak; Sung Il Kim; Jin Kuk Kim; Mary E Choi
Journal:  J Biol Chem       Date:  2008-05-16       Impact factor: 5.157

4.  Determinants of specificity in TGF-beta signal transduction.

Authors:  Y G Chen; A Hata; R S Lo; D Wotton; Y Shi; N Pavletich; J Massagué
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

5.  Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.

Authors:  M Kawabata; H Inoue; A Hanyu; T Imamura; K Miyazono
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

6.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.

Authors:  J J Lebrun; W W Vale
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

7.  Ligand-dependent and -independent interactions with the transforming growth factor type II and I receptor subunits reside in the aminoterminal portion of the ectodomain of the type III subunit.

Authors:  A Taniguchi; K Matsuzaki; K Nakano; M Kan; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

8.  TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Authors:  Tao Huang; Laurent David; Valentín Mendoza; Yong Yang; Maria Villarreal; Keya De; LuZhe Sun; Xiaohong Fang; Fernando López-Casillas; Jeffrey L Wrana; Andrew P Hinck
Journal:  EMBO J       Date:  2011-03-18       Impact factor: 11.598

9.  A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.

Authors:  X H Feng; R Derynck
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

10.  Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.

Authors:  Maya Mouler Rechtman; Alex Nakaryakov; Keren E Shapira; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.